Poster Exhibition

Monday, 4 August 2008

HIV-specific humoral immunity

Presentation type	Presentation day	Track	Poster Group	Text
All Oral abstracts Poster Discussions Poster Exhibition CD-ROM	All Sunday, 3 August 2008 Monday, 4 August 2008 Tuesday, 5 August 2008 Wednesday, 6 August 2008 Thursday, 7 August 2008 Friday, 8 August 2008	All A B C D E	All Access and availability of HIV/AIDS treatment and care, health services and mental health Access to therapy and strategies and models of delivery Acute early infection including infectivity Adherence Advocacy and lobbying by civil society, affected communities and PLWHAs Animal and cellular models of HIV pathogenesis Animal models for vaccine development Blood, organ and tissue safety Capacity building for HIV prevention research Capacity building for leadership and advocacy Clinical trials and antiretroviral therapy Community participation in research Compartmentalization Concepts of immune based therapy Cross-national comparisons Diagnosis, and disclosure of HIV disease Economic and human development dimensions of the epidemic Economic evaluation of prevention, care and mitigation programmes (including cost effectiveness) Economic strengthening initiatives (including micro-finance, health insurance, etc.) Efficiency and equity in access to treatment and prevention Epidemiology of HIV-1 and HIV-2 subtypes spreading Epidemiology of sexually transmitted infections (STI) and HIV Epidemiology of tuberculosis and HIV Epidemiology of viral hepatitis and HIV co-infection Epidemiology of vulnerabilities to HIV Ethical issues in prevention research Ethics (including research, clinical, public health and professional ethics) Ethnographic methods in HIV/AIDS research Evaluation of ARV delivery outcome in resource constrained settings Globalization and its effects, including structural adjustment and health sector reform HIV diversity and response to ARV HIV seroepidemiologic studies HIV/AIDS and the workplace, unemployment, return to work and rehabilitation HIV-specific cellular immunity HIV-specific humoral immunity Host genetic and HIV evolution Human resources and health systems Impact of donor agencies and policies on national responses Indigenous people and HIV Innate immunity Interventions to prevent mother-to-child transmission Intracellular restriction of HIV replication Male and female condoms and other physical barriers Male circumcision Maturation and assembly Mechanisms of immune dysfunction Media and cultural representations Methods for measuring vulnerability and social inequality Methods in social epidemiology Modeling Monitoring and evaluation of policies and their impact on PLWHA, affected communities and vulnerable populations Natural history, progression and survival Novel research designs in epidemiology Novel research designs in prevention research Pharmacology, pharmacokinetics, drug formulations Population-based surveys with HIV testing Provision of care, diagnosis and treatment for HIV exposed Risk behaviour, quality of life and access to care in harm reduction approaches Risk factors for acquisition of HIV Risk factors for infectivity, susceptibility, progression and transmission of HIV Roles and responsibilities of PLWHAs and vulnerable populations Roles and responsibilities of the state, civil society and private and business sectors Social and behavioural change theories, limits and possibilities Social class, poverty and socioeconomic stratification Socio-historical analyses of HIV/AIDS: the third decade Sustainability of ART programmes and adherence in developing countries Sustainability of financing Trade, patents and pharmaceutical production and availability Trends in morbidity and mortality Viral and host factors in long-term non progressors Viral dynamics and fitness Viral entry and tropism Viral regulatory genes Vulnerability reduction